Acadian Asset Management
NAUT icon

Acadian Asset Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Acadian Asset Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
1,055,461
+314,215
+42% +$830K ﹤0.01% 1083
2026
Q1 		$2.87M Buy
741,246
+129,262
+21% +$318K ﹤0.01% 847
2025
Q4 		$1.19M Buy
611,984
+368,711
+152% +$605K ﹤0.01% 1066
2025
Q3 		$203K Buy
243,273
+174,065
+252% +$128K ﹤0.01% 1398
2025
Q2 		$48K Buy
69,208
+7,473
+12% +$5.61K ﹤0.01% 1491
2025
Q1 		$51K Buy
61,735
+50,871
+468% +$75.6K ﹤0.01% 1437
2024
Q4 		$18K Buy
+10,864
New +$26K ﹤0.01% 1548
2023
Q1 		– Sell
-38,769
Closed -$69K – 1886
2022
Q4 		$69K Buy
+38,769
New +$74.8K ﹤0.01% 1511

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

Acadian Asset Management's NAUT Position: Q2 2026 in Review

Acadian Asset Management increased its Nautilus Biotechnolgy (NAUT) stake by 42% in Q2 2026, buying an estimated $830K and bringing the position to 1,055,461 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Acadian Asset Management first reported a position in NAUT in Q4 2022 and has held it in 8 quarters since. The position peaked at $2.87M in Q1 2026. 86 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Acadian Asset Management held 1,055,461 shares of Nautilus Biotechnolgy worth $1.97M as of Q2 2026.
  • Acadian Asset Management bought 314,215 Nautilus Biotechnolgy shares in Q2 2026, an estimated $830K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1083 holding.
  • Acadian Asset Management first reported a position in Nautilus Biotechnolgy in Q4 2022 and has held it in 8 quarters since.
  • Acadian Asset Management's Nautilus Biotechnolgy position peaked at $2.87M in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.